These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37197520)

  • 1. Efficacy and safety of colistin sulfate in the treatment of infections caused by carbapenem-resistant organisms: a multicenter retrospective cohort study.
    Peng D; Zhang F; Chen Y; Zhao C; Niu J; Yang J; Li Z; Chen C; Qiu S; Zhang H; Qin B; Fang X; Guo S; Liu Y; Shao H
    J Thorac Dis; 2023 Apr; 15(4):1794-1804. PubMed ID: 37197520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases.
    Wu Y; Jiang S; Li D; Wu Y; Li Q; Wang X; Liu B; Bao H; Wu D; Hu X
    Infect Dis Ther; 2024 Jan; 13(1):141-154. PubMed ID: 38212555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a prognostic nomogram to predict 30-day all-cause mortality in patients with CRO infection treated with colistin sulfate.
    Li W; Liu Y; Xiao L; Cai X; Gao W; Xu D; Han S; He Y
    Front Pharmacol; 2024; 15():1409998. PubMed ID: 39101134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli.
    Hao M; Yang Y; Guo Y; Wu S; Hu F; Qin X
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant gram-negative bacterial infections: a retrospective cohort study.
    Jin J; Zhu J; Zhu Z; Kim WY; O'Rourke J; Lin Z; Chen M
    Ann Transl Med; 2022 Oct; 10(20):1137. PubMed ID: 36388829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report.
    Peng D; Zhang F; Lv P; Chen Y; Yang J; Zhu W; Zhu S; Shao H
    Ann Transl Med; 2022 May; 10(10):614. PubMed ID: 35722356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of continuous renal replacement therapy on plasma concentration, clinical efficacy and safety of colistin sulfate].
    Peng D; Zhang F; Li Z; Lyu P; Guo Z; Chen Y; Zhao J; Niu J; Guo B; Jia W; Jiang X; Li X; Qi S; Qin B; Shao H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jan; 35(1):88-92. PubMed ID: 36880245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of polymyxin E sulfate in the treatment of critically ill patients with carbapenem-resistant organism infections.
    Lu X; Zhong C; Liu Y; Ye H; Qu J; Zong Z; Lv X
    Front Med (Lausanne); 2022; 9():1067548. PubMed ID: 36643845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Effectiveness and Safety of Colistin Sulphate in Treating Infections Caused by Carbapenem-Resistant Organisms and Analysis of Influencing Factors.
    Ma YC; Sun YQ; Wu X; Wang YJ; Yang XL; Gu JJ
    Infect Drug Resist; 2024; 17():3793-3804. PubMed ID: 39247753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study.
    Chen CY; Yang KY; Peng CK; Sheu CC; Chan MC; Feng JY; Wang SH; Chen CM; Zheng ZR; Liang SJ; Lin YC;
    Sci Rep; 2022 May; 12(1):7501. PubMed ID: 35525867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria.
    Xu HC; Cui Y; Wang XY; Wu HB; Li W; Wang D; Lin N; Lin L; Zhang YH
    World J Clin Cases; 2024 May; 12(13):2173-2181. PubMed ID: 38808336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of adjunctive nebulized colistin sulfate for multidrug-resistant Gram-negative bacteria pneumonia: a retrospective comparative cohort study.
    Bao XL; Tao T; Tang N; Wang YZ; Liao XQ; Huang LL; Ji JJ; Chen X
    Ann Palliat Med; 2022 Sep; 11(9):2939-2951. PubMed ID: 36217623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
    Nazer LH; Rihani S; Hawari FI; Le J
    Infect Dis (Lond); 2015; 47(11):755-60. PubMed ID: 26050703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.
    Dickstein Y; Leibovici L; Yahav D; Eliakim-Raz N; Daikos GL; Skiada A; Antoniadou A; Carmeli Y; Nutman A; Levi I; Adler A; Durante-Mangoni E; Andini R; Cavezza G; Mouton JW; Wijma RA; Theuretzbacher U; Friberg LE; Kristoffersson AN; Zusman O; Koppel F; Dishon Benattar Y; Altunin S; Paul M;
    BMJ Open; 2016 Apr; 6(4):e009956. PubMed ID: 27098822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study.
    Feng JY; Peng CK; Sheu CC; Lin YC; Chan MC; Wang SH; Chen CM; Shen YC; Zheng ZR; Lin YT; Yang KY;
    Clin Microbiol Infect; 2021 Oct; 27(10):1465-1473. PubMed ID: 33540113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
    Raz-Pasteur A; Liron Y; Amir-Ronen R; Abdelgani S; Ohanyan A; Geffen Y; Paul M
    J Glob Antimicrob Resist; 2019 Jun; 17():168-172. PubMed ID: 30557685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant
    Katip W; Uitrakul S; Oberdorfer P
    Antibiotics (Basel); 2020 Sep; 9(10):. PubMed ID: 32998187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacies of Colistin-Carbapenem versus Colistin-Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study.
    Wang SH; Yang KY; Sheu CC; Chen WC; Chan MC; Feng JY; Chen CM; Wu BR; Zheng ZR; Chou YC; Peng CK; On Behalf Of The T-Care Taiwan Critical Care Infection Group
    Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572663
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant
    Mazzitelli M; Gregori D; Sasset L; Trevenzoli M; Scaglione V; Lo Menzo S; Marinello S; Mengato D; Venturini F; Tiberio I; Navalesi P; Cattelan A
    Microorganisms; 2023 Apr; 11(4):. PubMed ID: 37110408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.